Richard Fitzgerald

Richard F.
Fitzgerald founded SIRPant Immunotherapeutics, Inc. in 2020, where he worked as Chief Financial Officer from 2020 to 2021.
Mr. Fitzgerald also currently works at Bucknell University Alumni Association, as Director, The American Institute of Certified Public Accountants, as Member, and Pennsylvania Institute of Certified Public Accountants, as Member.
Mr. Fitzgerald also formerly worked at Biotechnology Innovation Organization, as Co-Chairman, PECO Energy Co., as Director-Corporate Development in 2002, Exelon Corp., as Director-Corporate Development, Dillon Consulting Ltd., as Director, Nucleonics, Inc., as Chief Financial Officer & Vice President from 2002 to 2009, PricewaterhouseCoopers LLP, as Senior Manager-Audit & Transaction Services from 1985 to 1995, Techprecision Corp., as Chief Financial Officer & Head-Investor Relations from 2012 to 2015, 22nd Century Group, Inc., as Chief Financial Officer from 2021 to 2022, Immunome, Inc., as Chief Financial Officer in 2020, PAVmed, Inc., as Chief Financial Officer & Secretary from 2015 to 2017, Sesen Bio, Inc., as Chief Financial Officer & Treasurer in 2019, and CleanTech Acquisition Corp., as Chief Financial Officer.
Mr. Fitzgerald received his undergraduate degree from Bucknell University.